Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis

References

• Gutiérrez J, Morales P, González M A, et al. Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 2002; 42: 207–227
   PubMed Web of Science ®Google Scholar
• Sullivan D J, Moran G P, Pinjon E, et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004; 4: 369–376
   PubMed Web of Science ®Google Scholar
• Binolfi A, Biasoli M S, Luque A G, et al. High prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina. Med Mycol 2005; 43: 431–437
   PubMed Web of Science ®Google Scholar
• Kalkanci A, Kokturk N, Senol E, et al. Could Candida dubliniensis be involved in lung fungus balls?. Rev Iberoam Micol 2005; 22: 157–159
   PubMedGoogle Scholar
• Jabra-Rizk M A, Johnson J K, Forrest G, et al. Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin Infect Dis 2005; 41: 1064–1067
   PubMed Web of Science ®Google Scholar
• Tortorano A M, Peman J, Bernhardt H, et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317–322
   PubMed Web of Science ®Google Scholar
• Pfaller M A, Messer S A, Gee S, et al. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol 1999; 37: 870–872
   PubMed Web of Science ®Google Scholar
• Quindós G, Carrillo-Muñoz A J, Arévalo M P, et al. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Chemotherapy 2000; 46: 395–401
   PubMed Web of Science ®Google Scholar
• Quindós G, Ruesga M T, Martín-Mazuelos E, et al. In vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts. Rev Iberoam Micol 2004; 21: 63–69
   PubMedGoogle Scholar
• Al Mosaid A, Sullivan D J, Polacheck I, et al. Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting. J Clin Microbiol 2005; 43: 4026–4036
   PubMed Web of Science ®Google Scholar
• Moran G P, Sanglard D, Donnelly S M, et al. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 1998; 42: 1819–1830
   PubMed Web of Science ®Google Scholar
• Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998; 36: 2093–2095
   PubMed Web of Science ®Google Scholar
• Staib P, Morschhauser J. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 1999; 42: 521–524
   PubMed Web of Science ®Google Scholar
• Sahand I H, Moragues M D, Eraso E, et al. Supplementation of CHROMagar Candida medium with Pal's medium for rapid identification of Candida dubliniensis. J Clin Microbiol 2005; 43: 5768–5770
   PubMed Web of Science ®Google Scholar
• Jabra-Rizk M A, Brenner T M, Romagnoli M, et al. Evaluation of a reformulated CHROMagar Candida. J Clin Microbiol 2001; 39: 2015–2016
   PubMed Web of Science ®Google Scholar
• Bikandi J, San Millán R, Moragues M D, et al. Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J Clin Microbiol 1998; 36: 2428–2433
   PubMed Web of Science ®Google Scholar
• Brena S, Rubio M C, Salesa R, et al. Genotipos de Candida dubliniensis en aislamientos clínicos. Rev Iberoam Micol 2003; 21: 20–23
   Google Scholar
• Kanbe T, Horii T, Arishima T, Ozeki M, et al. PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast 2002; 19: 973–989
   PubMed Web of Science ®Google Scholar
• Cárdenes-Perera C D, Torres-Lana A, Alonso-Vargas R, et al. Evaluation of API ID 32C and VITEK-2 to identify Candida dubliniensis. Diagn Microbiol Infect Dis 2004; 50: 219–221
   PubMed Web of Science ®Google Scholar
• Al Mosaid A, Sullivan D J, Coleman D C. Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar. J Clin Microbiol 2003; 41: 4787–4789
   PubMed Web of Science ®Google Scholar
• Mosca C O, Moragues M D, Llovo J, et al. Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 2003; 41: 1259–1262
   PubMed Web of Science ®Google Scholar
• Kumar C P, Menon T. Tobacco agar: a new medium for chlamydosporulation in Candida albicans and Candida dubliniensis. Med Mycol 2005; 43: 473–475
   PubMed Web of Science ®Google Scholar
• Alves, S H, Linares, C E, Loreto, E S, , et al. Utilization of tomato juice agar (V8 agar) in the presumptive identification of Candida dubliniensis. Rev Soc Bras Med Trop 2006; 39: 92–93. [In Portuguese].
   PubMed Web of Science ®Google Scholar
• Marot-Leblond A, Beucher B, David S, et al. Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies. J Clin Microbiol 2006; 44: 138–142
   PubMed Web of Science ®Google Scholar
• Sahand I H, Moragues M D, Robert R, et al. Evaluation of Bichro-Dubli Fumouze to distinguish Candida dubliniensis from Candida albicans. Diagn Microbiol Infect Dis 2006; 55: 165–167
   PubMed Web of Science ®Google Scholar
• Alonso-Vargas R, Garaizar J, Pontón J, et al. Utilidad de la amplificación aleatoria de ADN en la diferenciación de Candida albicans y Candida dubliniensis. Rev Iberoam Micol 2000; 17: 10–13
   PubMedGoogle Scholar
• Kanbe T, Kurimoto K, Hattori H, et al. Rapid identification of Candida albicans and its related species Candida stellatoidea and Candida dubliniensis by a single PCR amplification using primers specific for the repetitive sequence (RPS) of Candida albicans. J Dermatol Sci 2005; 40: 43–50
   PubMed Web of Science ®Google Scholar
• Kirkpatrick W R, Revankar S G, McAtee R K, et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 1998; 36: 3007–3012
   PubMed Web of Science ®Google Scholar
• Hospenthal, D R, Beckius, M L, Floyd, K L, , et al. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob. 2006; 5: 1. Available online at http://www.ann-clinmicrob.com/content/5/1/1 (accessed on 13 January 2006).
   Google Scholar
• Schoofs A, Odds FC, Colebunders R, et al. Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes. Antimicrob Agents Chemother 1997; 41: 1625–1635
   PubMed Web of Science ®Google Scholar